Financial
-
-
-
-
-
-
-
Johnson & Johnson Reports 2016 Third-Quarter Results
Sales of $17.8 Billion Increased 4.2% versus 2015 Third Quarter Third-Quarter EPS was $1.53, Adjusted 2016 Third-Quarter EPS of $1.68 Increased 12.8%* -
Johnson & Johnson to Participate in the 2016 Wells Fargo 11th Annual Healthcare Conference
Johnson & Johnson (NYSE: JNJ) will participate in the 2016 Wells Fargo 11th Annual Healthcare Conference on Thursday, Sept. 8, at The Westin Boston Waterfront in Boston, MA. -